Neurology Archive

A building with a stone facade displays a sign that reads
David Wang, D.O., FAHA, FAAN
A building with a stone facade displays a sign that reads
Donald B. Penzien, Ph.D., FAHS, FSBM
A building with a stone facade displays a sign that reads
Suraj Muley, M.D., FAAN, FRCP
A building with a stone facade displays a sign that reads
Ashutosh P. Jadhav, M.D., Ph.D.
A building with a stone facade displays a sign that reads
An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Single Dose of Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (GBS) (FORWARD Study)
A building with a stone facade displays a sign that reads
A Multicenter Phase 1 / 2 Double-blind, Randomized, Sham-controlled Dose Escalation Study to Determine Safety and Tolerability of Single Dose Intrathecal ST-503 Gene Therapy for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
A building with a stone facade displays a sign that reads
Internet-delivered Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Outcomes and Exploration of Mechanisms
A building with a stone facade displays a sign that reads
A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
A building with a stone facade displays a sign that reads
A Phase 3, Randomized, Double-blind, Study Evaluating Efficacy and Safety of Riliprubart Versus Intravenous Immunoglobulin (IVIg) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy
A building with a stone facade displays a sign that reads
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Monotherapy in Patients With Symptomatic Generalized Myasthenia Gravis